Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Marcum MicroCap

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year’s Marcum MicroCap Conference.

Actinium Pharma, Inc. (ATNM) Starts Presentation at 2015 Marcum MicroCap Conference

Actinium Pharmaceuticals is a biopharmaceutical company focused on developing drugs to treat cancer. ATNM develops therapies for life threatening diseases using its alpha particle immunotherapy platform. Its product line-up lists Actimab-A and Iomab-B, currently in preparation for a phase 3 … Continue reading

Posted in Marcum MicroCap | Leave a comment

One Horizon Group, Inc. (OHGI) Starts Presentation at 2015 Marcum MicroCap Conference

One Horizon Group is engaged in optimizing communications over the Internet through its wholly owned subsidiary, Horizon Globex GmbH, Baar, which develops and markets mobile voice over Internet Protocol (VoIP) platforms for smartphones, and also offers a range of other … Continue reading

Posted in Marcum MicroCap | Leave a comment

Viggle, Inc. (VGGL) Starts Presentation at 2015 Marcum MicroCap Conference

Viggle is a mobile and web-based entertainment marketing platform for media companies, brands and consumers in the U.S. The company guides users towards various forms of media consumption with television enhancement, music discovery, entertainment content publishing, and distributed viewing reminders. … Continue reading

Posted in Marcum MicroCap | Leave a comment

Heat Biologics, Inc. (HTBX) Starts Presentation at 2015 Marcum MicroCap Conference

Heat Biologics is a clinical-stage cancer immunotherapy company focused on developing its novel, “off-the-shelf” ImPACT therapeutic vaccines to combat a wide range of cancers. ImPACT is designed to deliver live, genetically-modified, irradiated human cells which are reprogrammed to “pump out” a broad … Continue reading

Posted in Marcum MicroCap | Leave a comment

Pressure Biosciences, Inc. (PBIO) Starts Presentation at 2015 Marcum MicroCap Conference

Pressure Biosciences develops, markets and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. To date, the company has installed more than 250 pressure cycling technology (PCT) systems in approximately 160 sites … Continue reading

Posted in Marcum MicroCap | Leave a comment

Finjan Holdings, Inc. (FNJN) Starts Presentation at 2015 Marcum MicroCap Conference

Finjan Holdings by way of its subsidiary, Finjan, Inc., invests in and develops web and network cybersecurity technology. FNJN owns a patents related to software and hardware technologies that proactively detect malicious code and subsequently protect end-users from identity and … Continue reading

Posted in Marcum MicroCap | Leave a comment

Galmed Pharmaceuticals Ltd. (GLMD) Starts Presentation at 2015 Marcum MicroCap Conference

Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a new, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones. The company uses its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates to … Continue reading

Posted in Marcum MicroCap | Leave a comment

Iveda Solutions, Inc. (IVDA) Starts Presentation at 2015 Marcum MicroCap Conference

Iveda Solutions develops and sells software as a service video surveillance management platform under the name Sentir in the U.S. and around the world.  The Sentir platform is made up of surveillance software, cloud management software, servers, storage, and networking … Continue reading

Posted in Marcum MicroCap | Leave a comment

RestorGenex Corp. (RESX) Starts Presentation at 2015 Marcum MicroCap Conference

RestorGenex is a specialty biopharmaceutical company focused on developing a portfolio of first-in-class therapeutic products to treat diseases across the ophthalmologic, oncologic and dermatologic space. RestorGenex’s lead product is a novel PI3K/Akt/mTOR pathway inhibitor, which has completed two phase I … Continue reading

Posted in Marcum MicroCap | Leave a comment

Aemetis, Inc. (AMTX) Starts Presentation at 2015 Marcum MicroCap Conference

Aemetis is a renewable fuels and biochemicals company focused on the production of advanced fuels and chemicals through the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into … Continue reading

Posted in Marcum MicroCap | Leave a comment